DDDmitrii Dashevskii

Dmitrii Dashevskii

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Dmitrii Dashevskii has a total of 73 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Structure of a dodecameric double-ferritin-fold protein from an Asgard archaeon

    by Alina Remeeva, Arina Anuchina, Dmitrii Dashevskii, Tikhon Kurkin, Oleg Semenov, Alexey Mishin, Stepan Osipov, Guangyi Li, Pavel Shishkin, Yaroslav Shuvaev, et al.

    Ferritins are ubiquitous iron homeostasis proteins found across the tree of life that form conserved 24-subunit cages with octahedral (4-3-2) symmetry. New types of ferritins and ferritin-like proteins are being continuously discovered, such as mini-bacterioferritins, which form smaller shells of 12 subunits, and double-ferritin-fold proteins, which act as ferroxidases but do not form shells. Here, we describe double-ferritin-fold proteins from Asgard archaea, dubbed dFTNs, and determine Cryo-EM structure of a representative from Candidatus Heimdallarchaeum endolithica. The protein forms a dodecameric shell with tetrahedral (2-3) symmetry. N-terminal (NTD) and C-terminal (CTD) domains are bridged by an ordered linker and are related by two-fold rotational pseudosymmetry. C-terminal α-helix (helix E) that forms the four-fold channel in classic ferritins is repositioned to be the helix 2 out of 5 ferritin domain α-helices in dFTN, with two such helices from NTD and two helices from CTD forming a pseudo-four-fold symmetry structural element. Four three-fold channels are formed by NTDs, and four other such channels are formed by CTDs. The overall arrangement of dFTN ferritin domains is similar to that of protomers in classic ferritin shells. Altogether, our findings expand the range of known ferritin family proteins and provide insight into Asgard archaea iron metabolism.

  • Open Access

    Structural insights into human recoverin

    by Christopher O. MacCarthy, Alisa A. Vologzhannikova, Anatolii S. Belousov, Natalia N. Novikova, Victoria A. Rastrygina, Marina P. Shevelyova, Mikhail L. Shishkin, Natalia G. Shebardina, Mikhail B. Shevtsov, Ivan A. Kapranov, et al.

    Recoverin is a key calcium sensor that controls the desensitization of the visual rhodopsin by GRK1. Previous studies have traditionally been conducted on bovine protein (bRec), while data on human ortholog (hRec) remain scarce. Here, we combine X-ray crystallography, X-ray absorption spectroscopy (XANES), quantum mechanical calculations, molecular dynamics, and functional assays to provide an integrated characterization of hRec. The 2Ca 2+ -bound hRec structure was solved at 1.60 Å, showing that, unlike bRec, hRec interacts with ROS membranes at physiologically relevant submicromolar Ca 2+ levels, due to a species-specific charge distribution that might influence membrane interactions. Both recoverins form a set of Ca 2+ /Zn 2+ -bound conformers with improved functional performance. X-ray crystallography (1.85 Å) and XANES revealed a specific tetrahedral Zn 2+ site in 1Ca 2+ -bound hRec, the first such site reported in the NCS family. In 1Ca 2+ -bound hRec, zinc promotes the formation of active state, whereas in 2Ca 2+ -state of bRec, it significantly enhances GRK1 binding, as the latter can complement the Zn 2+ coordination. These data refine our understanding of recoverin function in humans and highlight its role as a key link between calcium and zinc signaling in mammalian photoreceptors under normal and pathological conditions.

  • Detergent‐mediated cryoprotection: Optimizing freezing and storage conditions for G protein‐coupled receptors

    by Ivan Kapranov, Igor Levashov, Aleksandra Luginina, Polina Khorn, Dmitii Dashevskii, Anatoliy Belousov, Nikolay Isaev, Natallia Strushkevich, Alexey Mishin, Valentin Borshchevskiy

    Cryoprotection is a widely employed approach in biophysical research for preserving protein integrity during storage and experimental analysis. While cryoconditions are generally considered optimal for preserving proteins, the freezing process can significantly alter solution properties, leading to protein denaturation or aggregation. To mitigate these detrimental effects, various cryoprotectants, such as glycerol or carbohydrates, are used. Membrane proteins, however, present unique challenges due to their reliance on specific lipid‐like environments for structural integrity and function. While established protocols are optimized for soluble proteins, the cryoprotection of membrane proteins remains poorly understood, often necessitating researchers to avoid freezing these proteins in their studies. Here, we investigate and optimize freezing conditions for membrane proteins, focusing on A2A adenosine receptor (A 2A AR)—a representative G protein‐coupled receptor (GPCR)—known for its environmental sensitivity. Our findings demonstrate that the appropriate detergent environment provides protection against cryogenic damage, enabling the successful freezing and long‐term storage of GPCRs, preserving their structural and functional integrity.

  • Optimization of Angiotensin II Receptor Type 1 Production for Biophysical Studies

    by I. A. Kapranov, P. A. Khorn, D. E. Dashevskii, A. P. Luginina, I. S. Levashov, H. Zhang, A. V. Mishin, V. I. Borshchevskiy

    The class of G protein-coupled receptors (GPCRs) represents a ubiquitous family of membrane proteins that selectively interact with a variety of signaling molecules to modulate cellular biochemical and physiological processes. Consequently, the structural and functional investigation of GPCRs is of paramount importance for both fundamental and applied scientific research. However, challenges arise in their recombinant expression, as well as subsequent extraction and purification, due to their inherent thermal instability and low yield. This necessitates the optimization of expression conditions and protocols for solubilization and purification. In this study, we focused on optimizing the expression, solubilization, and purification processes for the angiotensin II type 1 receptor (AT1), which plays a critical role in the physiology of the cardiovascular system. Several critical factors affecting receptor expression levels, yield, and monomericity were identified, facilitating an enhancement in the quality of the produced protein.

  • Unlocking GPCR–ligand interactions: Measuring binding affinities with thermal shift assay

    by Dmitrii Dashevskii, Aleksandra Luginina, Ivan Maslov, Marina Shevelyova, Polina Khorn, Daria Dmitrieva, Ivan Kapranov, Anatolii Belousov, Sergei Permyakov, Vadim Cherezov, et al.

    G protein‐coupled receptors (GPCRs) constitute the largest transmembrane protein superfamily, with over 800 representatives in the human genome. Recognized as pivotal targets in pharmacological research and drug discovery, these receptors play a crucial role in advancing therapeutics. Understanding the molecular mechanisms of receptor–ligand interactions is imperative for drug discovery applications. However, experimental procedures for measuring ligand binding are complicated by various factors, including the transmembrane nature of the receptors and the high cost associated with specialized instruments and consumables. Here we introduce an application of the thermal shift assay (TSA) to measuring ligand binding affinities for GPCRs. TSA is a cost‐effective and user‐friendly method that detects changes in protein stability induced by alterations in environmental conditions. Employing the human A2A adenosine receptor as a representative GPCR, we determined binding constants for four orthosteric ligands and allosteric sodium using three mathematical models for TSA data approximation and analysis. Models were additionally validated by two antagonists of cysteinyl leukotriene GPCR (CysLT1R), used as antiasthmatic drugs. Our results suggest that the TSA approach demonstrates a high degree of reproducibility and agreement with existing literature data, thereby affirming its suitability for investigating GPCR interactions with various types of ligands.


  • Functional GPCR Expression in Eukaryotic LEXSY System

    by Aleksandra Luginina, Ivan Maslov, Polina Khorn, Oleksandr Volkov, Andrey Khnykin, Pavel Kuzmichev, Mikhail Shevtsov, Anatoliy Belousov, Ivan Kapranov, Dmitrii Dashevskii, et al.


  • Open Access

    Functional GPCR expression in eukaryotic LEXSY system

    by Aleksandra Luginina, Ivan Maslov, Polina Khorn, Oleksandr Volkov, Andrey Khnykin, Pavel Kuzmichev, Mikhail Shevtsov, Anatoliy Belousov, Dmitrii Dashevskii, Daniil Kornilov, et al.

    G protein-coupled receptors (GPCRs) represent an important class of drug targets, and their structural studies facilitate rational drug discovery. However, atomic structures of only about 20% of human GPCRs have been solved to date. Recombinant production of GPCRs for structural studies at a large scale is challenging due to their low expression levels and stability. Here we tested the eukaryotic system LEXSY ( Leishmania tarentolae ) for GPCR production. We expressed the human A 2A adenosine receptor (A 2A AR) in LEXSY, purified it, and compared with the same receptor produced in insect cells, which is the most popular expression system for structural studies of GPCRs. The A 2A AR purified from both expression systems showed similar purity, stability, ligand-induced conformational changes and structural dynamics, with a remarkably higher protein yield in the case of LEXSY expression.